Schedule 13G ownership disclosure
MEREO BIOPHARMA GROUP PLC
Security class unavailable · CUSIP: 589492107
Event date: 2023-07-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 14,604,391
- Percent of class
- 2.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-089856
- Form type
- SC 13G
- Filer
- BAKER BROS. ADVISORS LP
- CIK
- CIK 1263508
- Filed
- Aug 10, 2023
- Reporting period
- Jul 31, 2023
- Description
- Schedule 13G beneficial ownership